OR5I1

Across TCGA pan-cancer cohorts, OR5I1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated OR5I1 data layer compared with 8 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher OR5I1 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated OR5I1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and LUSC show a favorable association.

UCEC, SCLC, and LIHC are the cancer types where OR5I1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	1.000	0.608	.002	36	view →
SCLC	OS	Median	III,IV	0.082	0.630	.001	9	view →
LIHC	OS	Median	III,IV	0.270	0.732	.021	9	view →
SKCM	DFS	Median	IV	0.016	0.454	<.001	9	view →
LUSC	OS	Median	All	0.788	0.391	.027	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

OR5I1–UCEC (DFS)

Open the UCEC breakdown →